G-CSF is a cornerstone of supportive care for patients undergoing chemotherapy, particularly those at high risk (≥20%) of febrile neutropenia22; these include most patients receiving chemotherapy for early breast cancer. This evidence concerns the gene CSF3 and breast carcinoma.